3 Biotech Stocks That Soared: Are They Buys?
Some of the biggest moves week in and week out come from biotech stocks. Whether it's a financial surprise, a positive clinical-trial update, regulatory approval, or even just rumors of potentially good news, biotech stocks can rise quickly.
Three biotech stocks did just that this past week, with gains of 18% to nearly 40%. Nektar Therapeutics (NASDAQ: NKTR), Wave Life Sciences (NASDAQ: WVE), and Savara soared over the past few days. Here's what lit a fire beneath these biotech stocks -- and whether they're buys after their huge gains.
Image source: Getty Images.
Source: Fool.com
Nektar Therapeutics Aktie
1,25 €
3,71 %
Die Community sieht Nektar Therapeutics leicht positiv: Mehr Buy- als Sell-Einschätzungen.
Ein prognostiziertes Kursziel von 2 € für Nektar Therapeutics zeigt ein Potenzial von über 50% im Vergleich zum aktuellen Kurs von 1.25 €.
